{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:11:45Z","timestamp":1790478705087,"version":"4.1.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"abstract":"<jats:sec id=\"ab-poi220051-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Oseltamivir is recommended for all children hospitalized with influenza, despite limited evidence supporting its use in the inpatient setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi220051-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether early oseltamivir use is associated with improved outcomes in children hospitalized with influenza.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi220051-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This multicenter retrospective study included 55\u202f799 children younger than 18 years who were hospitalized with influenza from October 1, 2007, to March 31, 2020, in 36 tertiary care pediatric hospitals who participate in the Pediatric Health Information System database. Data were analyzed from January 2021 to March 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi220051-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Early oseltamivir treatment, defined as use of oseltamivir on hospital day 0 or 1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi220051-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was hospital length of stay (LOS) in calendar days. Secondary outcomes included 7-day hospital readmission, late (hospital day 2 or later) intensive care unit (ICU) transfer, and a composite outcome of in-hospital death or use of extracorporeal membrane oxygenation (ECMO). Inverse probability treatment weighting (IPTW) based on propensity scoring was used to address confounding by indication. Mixed-effects models were used to compare outcomes between children who did and did not receive early oseltamivir treatment. Outcomes were also compared within high-risk subgroups based on age, presence of a complex chronic condition, early critical illness, and history of asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi220051-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis included 55\u202f799 encounters from 36 hospitals. The median (IQR) age of the cohort was 3.61 years (1.03-8.27); 56% were male, and 44% were female. A total of 33\u202f207 patients (59.5%) received early oseltamivir. In propensity score\u2013weighted models, we found that children treated with early oseltamivir had shorter LOS (median 3 vs 4 days; IPTW model ratio, 0.52; 95% CI, 0.52-0.53) and lower odds of all-cause 7-day hospital readmission (3.5% vs 4.8%; adjusted odds ratio [aOR], 0.72; 95% CI, 0.66-0.77), late ICU transfer (2.4% vs 5.5%; aOR, 0.41; 95% CI, 0.37-0.46), and the composite outcome of death or ECMO use (0.9% vs 1.4%; aOR, 0.63; 95% CI, 0.54-0.73).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-poi220051-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Early use of oseltamivir in hospitalized children was associated with shorter hospital stay and lower odds of 7-day readmission, ICU transfer, ECMO use, and death. These findings support the current recommendations for oseltamivir use in children hospitalized with influenza.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamapediatrics.2022.3261","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T11:32:23Z","timestamp":1663587143000},"page":"e223261","source":"Crossref","is-referenced-by-count":48,"title":["Association of Early Oseltamivir With Improved Outcomes in Hospitalized Children With Influenza, 2007-2020"],"prefix":"10.1001","volume":"176","author":[{"given":"Patrick S.","family":"Walsh","sequence":"first","affiliation":[{"name":"Division of Emergency Medicine, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schnadower","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Epidemiology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Ramgopal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois"},{"name":"Division of Emergency Medicine, Ann and Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir S.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio"},{"name":"Division of Hospital Medicine, Cincinnati Children's Hospital Medicine Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paria M.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"issue":"1","key":"poi220051r1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/irv.2018.12.issue-1","article-title":"Annual estimates of the burden of seasonal influenza in the United States: a tool for strengthening influenza surveillance and preparedness.","volume":"12","author":"Rolfes","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"poi220051r2","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1542\/peds.2007-0164","article-title":"Prevention of influenza: recommendations for influenza immunization of children, 2006-2007.","volume":"119","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2007","journal-title":"Pediatrics"},{"issue":"8","key":"poi220051r3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1086\/598513","article-title":"Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.","volume":"48","author":"Harper","year":"2009","journal-title":"Clin Infect Dis"},{"key":"poi220051r4","doi-asserted-by":"publisher","DOI":"10.1590\/1516-3180.20141324T2","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.","volume":"1","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"9979","key":"poi220051r5","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.","volume":"385","author":"Dobson","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"poi220051r6","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/cid\/cix1040","article-title":"Efficacy and safety of oseltamivir in children: systematic review and individual patient data meta-analysis of randomized controlled trials.","volume":"66","author":"Malosh","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"poi220051r7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3201\/eid2206.151037","article-title":"Debate regarding oseltamivir use for seasonal and pandemic influenza.","volume":"22","author":"Hurt","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"poi220051r8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"11","key":"poi220051r9","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/INF.0b013e318232ede9","article-title":"Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study.","volume":"30","author":"Coffin","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"poi220051r10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1542\/hpeds.2014-0045","article-title":"Hospital readmissions among children with H1N1 influenza infection.","volume":"4","author":"Brogan","year":"2014","journal-title":"Hosp Pediatr"},{"issue":"6","key":"poi220051r11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/PCC.0b013e318260114e","article-title":"Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*.","volume":"13","author":"Eriksson","year":"2012","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"poi220051r12","doi-asserted-by":"publisher","first-page":"e1539","DOI":"10.1542\/peds.2013-2149","article-title":"Neuraminidase inhibitors for critically ill children with influenza.","volume":"132","author":"Louie","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"poi220051r13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-050417","article-title":"Influenza antiviral treatment and length of stay.","volume":"148","author":"Campbell","year":"2021","journal-title":"Pediatrics"},{"issue":"11","key":"poi220051r14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1097\/INF.0000000000002447","article-title":"Risk factors for influenza virus related severe lower respiratory tract infection in children.","volume":"38","author":"Eski","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"poi220051r15","doi-asserted-by":"publisher","first-page":"g2371","DOI":"10.1136\/bmj.g2371","article-title":"Oseltamivir: the real world data.","volume":"348","author":"Freemantle","year":"2014","journal-title":"BMJ"},{"issue":"10","key":"poi220051r16","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/cid\/cix1150","article-title":"Oseltamivir treatment of influenza in children.","volume":"66","author":"Uyeki","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"10","key":"poi220051r19","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3201\/eid1210.051525","article-title":"ICD-9 codes for identifying influenza hospitalizations in children.","volume":"12","author":"Keren","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"poi220051r20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jpids\/pis052","article-title":"Use of administrative data for the identification of laboratory-confirmed influenza infection: the validity of influenza-specific ICD-9 codes.","volume":"2","author":"Feemster","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"4","key":"poi220051r21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology.","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"key":"poi220051r22","doi-asserted-by":"publisher","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes.","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"poi220051r23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2367","article-title":"Recommendations for prevention and control of influenza in children, 2018-2019.","volume":"142","author":"Committee on Infectious Diseases","year":"2018","journal-title":"Pediatrics"},{"issue":"6","key":"poi220051r24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"poi220051r25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation.","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"issue":"9","key":"poi220051r26","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.ajem.2018.12.015","article-title":"Characterizing pediatric high frequency users of California emergency departments.","volume":"37","author":"Supat","year":"2019","journal-title":"Am J Emerg Med"},{"key":"poi220051r18","volume-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Fingar","year":"2019"},{"key":"poi220051r17","unstructured":"Children\u2019s Hospital Association. Updated October 19, 2020. Accessed November 29, 2021. http:\/\/www.childrenshospitals.org"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2796162\/jamapediatrics_walsh_2022_oi_220051_1667596412.71116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T11:05:30Z","timestamp":1667819130000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2796162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2022.3261","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,7]]}}}